Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02301676Phase 4
Key facts
Phase 4, open-label trial of sevoflurane, propofol and dexmedetomidine in gallbladder disease (2 arms), sponsored by Pusan National University Hospital. Primary endpoint: The incidence of long-term postoperative cognitive dysfunction after general anesthesia in elderly patients at 2 years. Status: unknown.
General anesthesia & Control
Spouse control group assessed for cognitive function
Sevoflurane & Propofol & Dexmedetomidine
Patients undergoing laparoscopic cholecystectomy with one of the anesthetic methods
Elderly patients (>= 60 years) scheduled for laparoscopic cholecystectomy under general anesthesia. Excludes patients with CNS diseases (dementia MMSE <24), use of tranquilizers/antidepressants, previous neuropsychological testing, Parkinson's disease, severe sensory handicap, illiteracy, alcoholism, or drug dependence.
The incidence of long-term postoperative cognitive dysfunction after general anesthesia in elderly patients
The difference of incidence in postoperative cognitive dysfunction after general anesthesia according to the anesthetic drugs
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02301676.